Analyst consensus rating
LeonaBio Analyst Rating: none
Direct answer
LeonaBio's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $17.33.
Forecast evidence checked September 18, 2026.
Get free LeonaBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.71
- Average price target
- $17.33
- High price target
- $20.00
- Low price target
- $15.00
- Low target gap
- +123.5%
- Target upside
- +158.3%
- High target gap
- +198.1%
- Target range width
- 74.5%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- September 18, 2026
- Valid through
- September 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for LeonaBio?
LeonaBio has a verified none consensus. The same dataset has an average price target of $17.33.
How far are LeonaBio's low and high targets from the recorded price?
The low target implies +123.5%, while the high target implies +198.1%.
How many analysts are included in LeonaBio's consensus?
The verified consensus includes 3 analysts.
How is LeonaBio's target upside or downside calculated?
The average target of $17.33 is divided by the recorded price of $6.71, then one is subtracted to produce +158.3%. This does not guarantee a future return.
When was LeonaBio's analyst forecast verified?
The data was verified on 2026-09-18. The dataset is valid through 2026-09-25.